Resmed Inc
RMD · NYSE · United States · Health Care · HC Equipment & Services
- Coverage
- FY2017–FY2026
- History
- 10 years
- Latest filing
- 10-K · SEC EDGAR
- Reporting
- USD
- Fiscal year end
- June
- Last updated
- Aug 2026
Headline figures
Resmed Inc at a glance
In FY2026, Resmed Inc reported revenue of USD 5,653,443 thousands, EBITDA of USD -46,436 thousands, EBITDA margin of -0.8%.
| USD thousands | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | 5,146,327 | 5,653,443 | |||
| EBITDA | -162,248 | -46,436 | |||
| EBITDA margin | -3.2% | -0.8% | |||
| Free cash flow | 1,661,723 | 1,649,544 | |||
| ROIC | -5.8% | -4.0% |
The full 10-year history, every line item and each formula are in the platform.
In the platform
- Stat Book — normalized and as-reported IS, BS and CF
- Up to 10 years of annual and quarterly history
- Peer benchmarking and the stock screener
- Corporate risk scorecard
- DCF model from the filed inputs
- Tearsheet and live Excel formulas